Quick answers
- What is Voltaren Arthritis Pain?
- Voltaren Arthritis Pain is a brand name of Diclofenac, an over-the-counter medicine. The FDA NDC Directory lists 1 Voltaren Arthritis Pain product in 1 strength and form.
- Who makes Voltaren Arthritis Pain?
- Haleon US Holdings holds the FDA application for Voltaren Arthritis Pain (NDA022122, approved October 17, 2007).
- Is there a generic or store brand of Voltaren Arthritis Pain?
- Yes. The FDA NDC Directory lists 99 other products with the same active ingredients, strength and form as a Voltaren Arthritis Pain product, 99 of them generic or store brands. Ask your pharmacist whether one is right for you.
- Has Voltaren Arthritis Pain been recalled?
- No recall linked to Voltaren Arthritis Pain products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Voltaren Arthritis Pain is
Each Voltaren Arthritis Pain product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Diclofenac · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| diclofenac sodium 1% gel (topical) | Voltaren Arthritis Pain | 99 products, 69 companies | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Diclofenac →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022122 | Haleon US Holdings | October 17, 2007 | 1 |
Companies that list Voltaren Arthritis Pain
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Voltaren Arthritis Pain products.
- Haleon US Holdings LLC1 product
Recalls
No recall linked to Voltaren Arthritis Pain products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.